Blog - Blackandmed

High-Throughput Biomarker Panel for Rapid TBI Screening

by

March 28, 2025

The following is a summary of “A high-performance core laboratory GFAP/UCH-L1 test for the prediction of intracranial injury after mild ...

Regulatory Role of miR-16-5p in High Glucose–Treated HRECs

by

March 28, 2025

0

The following is a summary of “miR-16-5p Regulates Proliferation and Apoptosis in High Glucose–Treated Human Retinal Microvascular Endothelial Cells by ...

Socioeconomic Position and Placebo Analgesia in Chronic Pain

by

March 28, 2025

0

The following is a summary of “Effects of socioeconomic position on endogenous pain modulation: A quasi-experimental approach,” published in the ...

Short-Term Benefits of Fractional Laser in Menopausal Care

by

March 28, 2025

0

The following is a summary of “Efficacy of Fractionated Carbon Dioxide Laser for the Treatment of Genitourinary Syndrome of Menopause,” ...

Chinese Woman Is Third Person to Get a Gene-Edited Pig Kidney

by

March 28, 2025

0

THURSDAY, March 27, 2025 (HealthDay News) — A Chinese woman is the third person in the world living with a ...

Five Top CDC Leaders Step Down Amid Wave of Departures

by

March 28, 2025

0

THURSDAY, March 27, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) is facing major changes, ...

NIH Ends Funding for the Effects of Climate Change on Health

by

March 28, 2025

0

THURSDAY, March 27, 2025 (HealthDay News) — The National Institutes of Health (NIH) will no longer fund new research on ...

Use of Parallel Transmit 7T MRI Changes Management for Epilepsy Surgery

by

March 28, 2025

0

THURSDAY, March 27, 2025 (HealthDay News) — Parallel transmit (pTx) 7 Tesla (T) magnetic resonance imaging (MRI) changes management in ...

Pelabresib Plus Ruxolitinib Improves Underlying Myelofibrosis

by

March 28, 2025

0

THURSDAY, March 27, 2025 (HealthDay News) — Pelabresib, a bromodomain and extraterminal domain inhibitor, plus ruxolitinib (a Janus kinase inhibitor) ...